Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow (FCF).

## 1093 Free Cash Flow Analysis

Free cash flow, a measure commonly used by analysts to assess a company's profitability, represents the cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

The Free Cash Flow is calculated using a number of methods including using Operating Cash Flow. Following is the formula to calculate Free Cash Flow based on Operating Cash Flow.

`Free Cash Flow = Operating Cash Flow - Capital Expenditures`

Using above formula to calculate Free Cash Flow for CSPC Pharmaceutical Group Limited (1093), the free cash flow value is 3.226481B.

All amounts in CNY

Operating Cash
4.64B
Capital Expenditure
-1.41B
Free Cash Flow
3.226481B

CSPC Pharmaceutical Group Limited has a positive free cash flow as per the latest annual Cash flow statement released by the company. Positive free cash flow is cruscial for the financial health of a company, which can be used to pay dividends, expand operations, and deleverage its balance sheet (i.e., reduce debt).

## 1093 Cash Flow Statement History

Following table shows the history of Cash Flow Statements sheet for CSPC Pharmaceutical Group Limited (HKEX:1093).

31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Net Income 5.61B 5.16B 3.71B 3.08B
Depreciation 862.38M 804.45M 686.67M 607.41M
Change To Netincome -446.11M -909.03M -136.99M -145.9M
Change To Account Receivables -943.55M -445.45M -196.74M -519.66M
Change To Liabilities 232.57M 629.28M -572.97M 593.83M
Change To Inventory -617.07M 601.44M 509.31M -614.03M
Change To Operating Activities -59.87M 894.92M -224.41M 770.4M
Total Cash From Operating Activities 4.64B 6.74B 3.78B 3.8B
Capital Expenditures -1.41B -1.36B -1.88B -1.67B
Investments 630.71M -450.06M 261.06M -1.44B
Other Cashflows From Investing Activities 269M -10.01M -267.2M -190.05M
Total Cashflows From Investing Activities -637.33M -2.13B -2.46B -3.63B
Dividends Paid -1.69B -1.53B -965.38M -782.88M
Net Borrowings -222.17M 76.68M -1.63B 714.11M
Other Cashflows From Financing Activities -20.16M -19.96M 1.15B 809k
Total Cash From Financing Activities -2.2B -1.47B -1.55B -151.39M
Effect Of Exchange Rate -2.44M 2.1M 1.46M 3.01M
Change In Cash 1.8B 3.14B -217.38M 19.05M
Repurchase Of Stock -263.51M -263.51M -100.71M -83.43M